276 related articles for article (PubMed ID: 20182422)
1. Interleukin-6 as a therapeutic target in candidate inflammatory diseases.
Nishimoto N
Clin Pharmacol Ther; 2010 Apr; 87(4):483-7. PubMed ID: 20182422
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6: from bench to bedside.
Nishimoto N; Kishimoto T
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IL-6 for the treatment of inflammatory diseases.
Nishimoto N; Kishimoto T
Curr Opin Pharmacol; 2004 Aug; 4(4):386-91. PubMed ID: 15251133
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
Monteleone G; Pallone F; Macdonald TT
Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
[TBL] [Abstract][Full Text] [Related]
5. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
6. IL-6 signal transduction and its physiological roles: the signal orchestration model.
Kamimura D; Ishihara K; Hirano T
Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
[TBL] [Abstract][Full Text] [Related]
7. [Anti-cytokines in the treatment of inflammation].
Mariette X
Rev Prat; 2003 Mar; 53(5):507-11. PubMed ID: 12722608
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of inflammation with anti-inflammatory cytokines: example in models of auto-immune diseases].
Bessis N; Fradelizi D; Fournier C; Boissier MC
C R Seances Soc Biol Fil; 1995; 189(4):579-90. PubMed ID: 8564571
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M
Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 as a drug target in human disease.
Ivanov S; Lindén A
Trends Pharmacol Sci; 2009 Feb; 30(2):95-103. PubMed ID: 19162337
[TBL] [Abstract][Full Text] [Related]
11. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
Akira S; Kishimoto T
Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
Herman S; Krönke G; Schett G
Trends Mol Med; 2008 Jun; 14(6):245-53. PubMed ID: 18468489
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers.
Ho LJ; Luo SF; Lai JH
Biochem Pharmacol; 2015 Sep; 97(1):16-26. PubMed ID: 26080005
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin-6 receptor antibody therapy in rheumatic diseases.
Nakahara H; Nishimoto N
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):373-81. PubMed ID: 17214583
[TBL] [Abstract][Full Text] [Related]
15. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
Tanaka T; Narazaki M; Ogata A; Kishimoto T
Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of the interleukin-6 receptor.
Tanaka T; Narazaki M; Kishimoto T
Annu Rev Pharmacol Toxicol; 2012; 52():199-219. PubMed ID: 21910626
[TBL] [Abstract][Full Text] [Related]
17. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
18. Gene of the month: Interleukin 6 (IL-6).
Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 signaling pathway in targeted therapy for cancer.
Guo Y; Xu F; Lu T; Duan Z; Zhang Z
Cancer Treat Rev; 2012 Nov; 38(7):904-10. PubMed ID: 22651903
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases.
Dinarello CA
Semin Immunol; 1992 Jun; 4(3):133-45. PubMed ID: 1320950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]